Angeles Investment Advisors LLC Invests $242,000 in Colgate-Palmolive (NYSE:CL)

Angeles Investment Advisors LLC bought a new position in Colgate-Palmolive (NYSE:CL) in the second quarter, HoldingsChannel.com reports. The fund bought 2,492 shares of the company’s stock, valued at approximately $242,000.

A number of other hedge funds have also modified their holdings of CL. Union Savings Bank raised its holdings in shares of Colgate-Palmolive by 76.6% in the 4th quarter. Union Savings Bank now owns 309 shares of the company’s stock worth $25,000 after buying an additional 134 shares in the last quarter. E Fund Management Hong Kong Co. Ltd. acquired a new position in shares of Colgate-Palmolive in the 2nd quarter worth approximately $25,000. PSI Advisors LLC increased its holdings in Colgate-Palmolive by 4,971.4% during the 1st quarter. PSI Advisors LLC now owns 355 shares of the company’s stock valued at $32,000 after purchasing an additional 348 shares in the last quarter. Core Wealth Advisors Inc. raised its position in Colgate-Palmolive by 56.6% in the 4th quarter. Core Wealth Advisors Inc. now owns 404 shares of the company’s stock valued at $32,000 after purchasing an additional 146 shares during the last quarter. Finally, Rise Advisors LLC bought a new position in Colgate-Palmolive in the 1st quarter valued at $38,000. 80.41% of the stock is owned by institutional investors and hedge funds.

Colgate-Palmolive Trading Down 0.3 %

Shares of NYSE CL opened at $105.43 on Tuesday. Colgate-Palmolive has a twelve month low of $67.62 and a twelve month high of $109.30. The stock has a market cap of $86.50 billion, a price-to-earnings ratio of 33.36, a P/E/G ratio of 3.72 and a beta of 0.40. The company has a quick ratio of 0.70, a current ratio of 1.06 and a debt-to-equity ratio of 16.90. The company’s fifty day moving average is $102.26 and its 200-day moving average is $95.43.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, July 26th. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.87 by $0.04. Colgate-Palmolive had a return on equity of 470.19% and a net margin of 14.21%. The firm had revenue of $5.06 billion for the quarter, compared to analyst estimates of $5 billion. During the same period in the previous year, the company posted $0.77 earnings per share. The company’s revenue for the quarter was up 4.9% on a year-over-year basis. Equities research analysts predict that Colgate-Palmolive will post 3.57 EPS for the current year.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be paid a dividend of $0.50 per share. The ex-dividend date of this dividend is Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a yield of 1.90%. Colgate-Palmolive’s payout ratio is 63.29%.

Insiders Place Their Bets

In other Colgate-Palmolive news, insider Sally Massey sold 15,850 shares of the firm’s stock in a transaction that occurred on Tuesday, August 6th. The shares were sold at an average price of $103.28, for a total transaction of $1,636,988.00. Following the sale, the insider now directly owns 13,942 shares in the company, valued at approximately $1,439,929.76. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other Colgate-Palmolive news, insider Panagiotis Tsourapas sold 14,794 shares of the firm’s stock in a transaction that occurred on Thursday, August 8th. The shares were sold at an average price of $102.94, for a total transaction of $1,522,894.36. Following the sale, the insider now directly owns 5,146 shares in the company, valued at approximately $529,729.24. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Sally Massey sold 15,850 shares of the firm’s stock in a transaction that occurred on Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total transaction of $1,636,988.00. Following the sale, the insider now owns 13,942 shares in the company, valued at $1,439,929.76. The disclosure for this sale can be found here. In the last three months, insiders have sold 43,490 shares of company stock worth $4,486,063. Company insiders own 0.34% of the company’s stock.

Analysts Set New Price Targets

CL has been the subject of several research analyst reports. Hsbc Global Res downgraded Colgate-Palmolive from a “strong-buy” rating to a “hold” rating in a research report on Friday, July 26th. HSBC reiterated a “hold” rating on shares of Colgate-Palmolive in a research report on Friday, July 26th. Barclays lifted their price objective on Colgate-Palmolive from $91.00 to $96.00 and gave the company an “equal weight” rating in a research report on Monday, July 29th. UBS Group lifted their price objective on Colgate-Palmolive from $119.00 to $122.00 and gave the company a “buy” rating in a research report on Wednesday, September 4th. Finally, Citigroup lifted their target price on Colgate-Palmolive from $103.00 to $112.00 and gave the company a “buy” rating in a research note on Wednesday, July 10th. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $102.79.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.